肺癌中的生物标志物。

Biomarkers in lung cancer.

作者信息

Bearz Alessandra, Berretta Massimiliano, Cappellani Alessandro, Lleshi Arben, Berto Eleonora, Fratino Lucia, Tirelli Umberto

机构信息

Department of Medical Oncology, CRO-IRCCS, National Cancer Institute, Aviano, PN, Italy.

出版信息

Front Biosci (Elite Ed). 2010 Jun 1;2(3):1099-104. doi: 10.2741/e168.

DOI:10.2741/e168

PMID:20515780

Abstract

Here we review the role of tissutal and circulating biomarkers in the management of lung cancer. In the past they were considerate quite ineffective tools as regards prognosis and prediction of treatment activity, nowadays instead, they are becoming a crucial key point as potential predictive issues in driving therapy, with possibly prognostic values as well.

摘要

在此，我们回顾组织和循环生物标志物在肺癌管理中的作用。过去，就预后和治疗活性预测而言，它们被认为是相当无效的工具，而如今，它们正成为驱动治疗中潜在预测问题的关键要点，可能还具有预后价值。